Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03619863 · ClinicalTrials.gov registry record
ATHN 7: Hemophilia Natural History Study
A clinical trial, sponsored by American Thrombosis and Hemostasis Network.
- Completed
- Registry status
- 395
- Enrollment target
NCT03619863 is a clinical trial that has completed, run by American Thrombosis and Hemostasis Network. The registered enrollment target is 395 participants.
The verdict
NCT03619863 has completed, sponsored by American Thrombosis and Hemostasis Network.
- COMPLETED
- Registry status
- 395 participants
- Enrollment target
Study Summary
This is a real-world study of the safety of the treatments used for people with hemophilia. The study will follow people with hemophilia A or B from across the country for about 4 years as they receive treatment. The hemophilia treatment center (HTC) physician and participant will decide on the FDA-approved treatment to be used which may include non-factor products, bypassing agents, or clotting factor replacement products. The goal of this research is to study the use of hemophilia treatment products and their outcomes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 395 participants |
| Start Date | 2018-10-24 |
| Est. Completion | 2024-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03619863
The ClinicalTrials.gov registry entry for NCT03619863 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 395 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is American Thrombosis and Hemostasis Network, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03619863 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03619863 about?
NCT03619863 is a clinical study titled "ATHN 7: Hemophilia Natural History Study". This is a real-world study of the safety of the treatments used for people with hemophilia. The study will follow people with hemophilia A or B from across the country for about 4 years as they receive treatment. The hemophilia treatment center (HTC) physician and participant will decide on the FDA-...
What is the current status of trial NCT03619863?
This trial is currently completed. The enrollment target is 395 participants. The study started on 2018-10-24. Estimated completion is 2024-03-31.
Who is sponsoring clinical trial NCT03619863?
This trial is sponsored by American Thrombosis and Hemostasis Network, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.